These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28971986)

  • 21. Streamlined Genetic Education and Cascade Testing in Men from Hereditary Breast Ovarian Cancer Families: A Randomized Trial.
    Grisham C; Peshkin BN; Sorgen L; Isaacs C; Ladd MK; Jacobs A; Binion S; Tynan M; Kuchinsky E; Friedman S; Taylor KL; Graves K; O'Neill S; Kim D; Schwartz MD
    Public Health Genomics; 2024; 27(1):100-109. PubMed ID: 39173603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.
    Demarco TA; Nusbaum RH; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Tercyak KP
    Patient Educ Couns; 2010 Jan; 78(1):29-33. PubMed ID: 19545972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.
    Manchanda R; Burnell M; Loggenberg K; Desai R; Wardle J; Sanderson SC; Gessler S; Side L; Balogun N; Kumar A; Dorkins H; Wallis Y; Chapman C; Tomlinson I; Taylor R; Jacobs C; Legood R; Raikou M; McGuire A; Beller U; Menon U; Jacobs I
    J Med Genet; 2016 Jul; 53(7):472-80. PubMed ID: 26993268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.
    Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA
    J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.
    Nilsson MP; Nilsson ED; Silfverberg B; Borg Å; Loman N
    Genet Med; 2019 Jan; 21(1):89-96. PubMed ID: 29875420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
    Høberg-Vetti H; Bjorvatn C; Fiane BE; Aas T; Woie K; Espelid H; Rusken T; Eikesdal HP; Listøl W; Haavind MT; Knappskog PM; Haukanes BI; Steen VM; Hoogerbrugge N
    Eur J Hum Genet; 2016 Jun; 24(6):881-8. PubMed ID: 26350514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary breast and ovarian cancer syndrome : the impact of race on uptake of genetic counseling and testing.
    Simon MS; Petrucelli N
    Methods Mol Biol; 2009; 471():487-500. PubMed ID: 19109796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.
    Raphael J; Verma S; Hewitt P; Eisen A
    J Genet Couns; 2016 Dec; 25(6):1309-1316. PubMed ID: 27228984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
    Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
    Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost effectiveness analysis of genetic testing for breast and ovarian cancer susceptibility genes: BRCA1 and BRCA2.
    Kaldate R; Huston A; McCoy H; Cardeiro D; Noyes K
    Breast J; 2014; 20(3):325-6. PubMed ID: 24708220
    [No Abstract]   [Full Text] [Related]  

  • 37. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.
    Peshkin BN; Kelly S; Nusbaum RH; Similuk M; DeMarco TA; Hooker GW; Valdimarsdottir HB; Forman AD; Joines JR; Davis C; McCormick SR; McKinnon W; Graves KD; Isaacs C; Garber J; Wood M; Jandorf L; Schwartz MD
    J Genet Couns; 2016 Jun; 25(3):472-82. PubMed ID: 26455498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
    Wang C; Gonzalez R; Milliron KJ; Strecher VJ; Merajver SD
    Am J Med Genet A; 2005 Apr; 134A(1):66-73. PubMed ID: 15690408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
    Cragun D; Bonner D; Kim J; Akbari MR; Narod SA; Gomez-Fuego A; Garcia JD; Vadaparampil ST; Pal T
    Breast Cancer Res Treat; 2015 May; 151(1):169-76. PubMed ID: 25868867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.